PHARMAJET, INC.

PharmaJet is a needle-free injection technology company founded in 2005 and headquartered in Golden, Colorado. The company develops innovative jet injection systems designed to improve vaccine and pharmaceutical delivery while addressing critical healthcare challenges including needle reuse, needlestick injuries, and infection transmission. PharmaJet's proprietary needle-free systems deliver injectable drugs with precision and safety across therapeutic areas including vaccines, immunotherapy, and oncology treatments. The company has established partnerships with over 80 global pharmaceutical manufacturers, government health agencies including the World Health Organization, and public health organizations. PharmaJet's technology has demonstrated clinical benefits: 97% vaccinator preference, 25% faster administration workflow, 54% reduction in adverse events, and improved immunization coverage. The systems are designed to be cost-effective, reusable, require no drug reformulation, and integrate seamlessly with existing fill-finish manufacturing processes. PharmaJet serves healthcare providers, pharmaceutical partners, and patients globally with regulatory-cleared delivery systems.